Login / Signup

Nutritional Status Predicts Fatty Acid Uptake from Fish and Soybean Oil Supplements for Treatment of Cancer-Related Fatigue: Results from a Phase II Nationwide Study.

Amber S KlecknerEva CulakovaIan R KlecknerElizabeth K BelcherWendy Demark-WahnefriedElizabeth A ParkerGilbert D A PadulaMary OntkoMichelle C JanelsinsKaren M MustianLuke J Peppone
Published in: Nutrients (2021)
Cancer-related fatigue is a prevalent and debilitating condition that persists for years into survivorship. Studies evaluating both fish oil supplementation on fatigue and associations between fish oil consumption and fatigue have shown mixed effects; it is unknown what factors contribute to these differential effects. Herein, we investigate whether the nutritional status of cancer survivors was associated with serum omega-3 concentration or change in serum omega-3s throughout a fish oil supplementation study, and then if any of these factors were associated with fatigue. Breast cancer survivors 4-36 months post-treatment with moderate-severe fatigue were randomized to take 6 g fish oil, 6 g soybean oil, or 3 g of each daily for 6 weeks. Baseline nutritional status was calculated using the Controlling Nutritional Status tool (serum albumin, lymphocytes, cholesterol). At baseline and post-intervention, serum fatty acids were quantified and fatigue was assessed using the Multidimensional Fatigue Symptom Inventory. Participants ( n = 85) were 61.2 ± 9.7 years old with a body mass index of 31.9 ± 6.7 kg/m 2 ; 69% had a good nutritional score and 31% had light-moderate malnutrition. Those with good nutritional status had greater total serum omega-3s at baseline ( p = 0.013) and a greater increase in serum omega-3s with supplementation ( p = 0.003). Among those who were supplemented with fish oil, greater increases in serum omega-3s were associated with greater improvements in fatigue. In conclusion, good nutritional status may increase uptake of fatty acid supplements, increasing their ability to improve fatigue.
Keyphrases
  • fatty acid
  • sleep quality
  • body mass index
  • phase ii
  • clinical trial
  • randomized controlled trial
  • open label
  • double blind
  • depressive symptoms
  • early onset
  • placebo controlled
  • phase iii
  • preterm birth